These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13328357)

  • 1. [Phenylbutazone in therapy of Hodgkin's disease].
    ALCOZER G; AZZENA D
    Arch Maragliano Patol Clin; 1956 Feb; 12(1):107-16. PubMed ID: 13328357
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phenylbutazone in the treatment of Hodgkin's disease].
    GILSANZ V; SEGOVIA JM; PALACIOS JM
    Rev Clin Esp; 1955 Aug; 58(3):150-4. PubMed ID: 13281037
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenylbutazone (butazolidin) in the treatment of Hodgkin's disease.
    BICHEL J
    Acta Med Scand; 1956 Jan; 153(4):293-8. PubMed ID: 13301460
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenylbutazone (butazolidin), a useful chemotherapeutic agent for Hodgkin's disease.
    ROTTINO A; JOFFE A; HOFFMANN G
    AMA Arch Intern Med; 1954 Apr; 93(4):561-70. PubMed ID: 13137632
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phenylbutazone (butazolidine) in malignant granulomatosis (mb. Hodgkin)].
    BICHEL J
    Nord Med; 1956 Feb; 55(8):262-3. PubMed ID: 13309795
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenylbutazone in Hodgkin's disease.
    DESHMUKH PL
    J Indian Med Assoc; 1956 Aug; 27(3):103. PubMed ID: 13367425
    [No Abstract]   [Full Text] [Related]  

  • 7. [Butazolidine in the treatment of malignant granuloma].
    PACZYNSKI ZA; PACZYNSKA D; WLODARCZYK J
    Pol Arch Med Wewn; 1962; 32():75-80. PubMed ID: 14483082
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and experimental studies on butazolidine effects and its application in leukemias, neoplastic processes and lymphogranulomatosis].
    HEILMEYER L; HARWERTH HG; DOXIE J; KRAUSS R
    Arzneimittelforschung; 1953 Apr; 3(4):161-75. PubMed ID: 13081446
    [No Abstract]   [Full Text] [Related]  

  • 9. [Usefulness of phenylbutazone as a diagnostic element in Hodgkin's disease].
    AGUIRRE M; TORRES JA; DE OYA JC
    Rev Clin Esp; 1963 May; 89():180-1. PubMed ID: 14041493
    [No Abstract]   [Full Text] [Related]  

  • 10. [HODGKIN'S DISEASE WITH ACQUIRED ICTHYOSIS].
    POINSO R; CALAS E; JAUFFRET P; POGGI L
    Mars Med; 1964; 101():697-700. PubMed ID: 14207167
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phenylbutazone, adjuvant in treatment of malignant hemopathy and especially Hodgkin's disease].
    Coeur P
    Therapeutique; 1969 Oct; 45(8):780-5. PubMed ID: 5386090
    [No Abstract]   [Full Text] [Related]  

  • 12. [Utilization of phenylbutazone in malignant lymphogranuloma and in other malignant diseases; indications and limitations].
    DI PIETRO S; VESCIA E
    Minerva Med; 1956 Jul; 47(59-60):273-6. PubMed ID: 13378169
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences in the reatment of lymphogranulomatosis].
    RUNGE A
    Z Gesamte Inn Med; 1962 Jul; 17():614-6. PubMed ID: 13975546
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indication of phenylbutazone therapy in certain unusual diseases].
    MAMPEL E
    Ther Ggw; 1958 Jun; 97(6):230-3. PubMed ID: 13569402
    [No Abstract]   [Full Text] [Related]  

  • 15. THE USE OF RHEOSOLONE IN THE TREATMENT OF MALIGNANT LYMPHOCYTOMA.
    ERDOES B
    Ther Hung; 1963; 11():28-9. PubMed ID: 14090237
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of chloramphenicol on Hodgkin's disease].
    DESMONTS T
    Sang; 1954; 25(6):653. PubMed ID: 13195568
    [No Abstract]   [Full Text] [Related]  

  • 17. Cortisone in the treatment of Hodgkin's disease.
    ANDERSON JF; IRVINE GT
    Treat Serv Bull; 1951 Nov; 6(10):470-2. PubMed ID: 14893448
    [No Abstract]   [Full Text] [Related]  

  • 18. [Four cases of Hodgkin's disease treated with colchicine].
    ISCH-WALL P
    Sang; 1952; 23(8):689-93. PubMed ID: 13004927
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic use of anti-reticular cytotoxic serum in Hodgkin's disease.
    SKAPIER J
    Cancer Res; 1947 Jun; 7(6):369-71. PubMed ID: 18909138
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of lymphogranuloma; Hodgkin's disease].
    ALDER A; ZBINDEN F
    Schweiz Med Wochenschr; 1953 Sep; 83(39):924-7. PubMed ID: 13101670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.